AnazaoHealth Corporation

FDA Regulatory Profile

AnazaoHealth Corporation appears in FDA public data with 3 recalls, 0 510(k) clearances, 5 FDA inspections, and 2 compliance actions on record. Its most recent recall (D-0204-2024, Class II) was initiated on November 22, 2023.

Summary

Total Recalls
3
510(k) Clearances
0
Inspections
5
Compliance Actions
2

Recent Recalls

NumberClassProductDate
D-0204-2024Class IIThiamine HCl/Pyridoxine HCl 20 mg/mL /100mg/ml Injection Solution, 30mL Amber Glass Vial, Rx only, ANovember 22, 2023
D-0203-2024Class IIB-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/7November 22, 2023
D0384-2015Class IICompounded Plaquex, intravenous injection, 50 ML vial. Each ml contains: Phosphatidyl Choline 50 mJanuary 26, 2015